Showing results (1-10 of 246) with videos related to
Sort By:
Pageof 25
Current Protocols|December 5, 2025
Immune Modulation in Cancer: The Role of Tumor-Treating Fields (TTFields)Menglan Liu, Maria El Hage, Jihui Zhao, et al.International Journal of Molecular Sciences|June 13, 2025
Mutational Patterns in Colorectal Cancer: Do PDX Models Retain the Heterogeneity of the Original Tumor?Maria El Hage, Zhaoran Su, Michael LinnebacherCancers|April 14, 2025
Addressing Challenges in Targeted Therapy for Metastatic Colorectal CancerMaria El Hage, Zhaoran Su, Michael LinnebacherHeliyon|September 12, 2024
Mutation patterns in colorectal cancer and their relationship with prognosisZhaoran Su, Maria El Hage, Michael LinnebacherApoptosis : an International Journal on Programmed Cell Death|February 4, 2025
The impact of SEC23A on 5-FU chemotherapy sensitivity and its involvement in endoplasmic reticulum stress-induced apoptosis in colorectal cancerZhaoran Su, Menglan Liu, Mathias Krohn, et al.Cancer Medicine|May 19, 2025
Optimization of Tumor Treating Fields (TTFields) Frequency and Treatment Duration in Colorectal Cancer CellsMenglan Liu, Zhaoran Su, Paul-Philipp Hagemann, et al.World Journal of Gastroenterology|January 18, 2013
Tumor-infiltrating B cells come into vogueMichael LinnebacherNPJ Precision Oncology|May 26, 2026
NAALADL1 modulates cellular resistance to Tumor Treating Fields in colorectal cancerZhaoran Su, Menglan Liu, Mathias Krohn, et al.Oncoimmunology|November 22, 2012
Tumor-infiltrating B cells: The ignored players in tumor immunologyMichael Linnebacher, Claudia MaletzkiCancer Immunology, Immunotherapy : CII|December 22, 2011
Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopesChristina S Mullins, Michael LinnebacherPageof 25